BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 25937010)

  • 1. Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway.
    Richardson BG; Jain AD; Speltz TE; Moore TW
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2261-8. PubMed ID: 25937010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators.
    Jain AD; Potteti H; Richardson BG; Kingsley L; Luciano JP; Ryuzoji AF; Lee H; Krunic A; Mesecar AD; Reddy SP; Moore TW
    Eur J Med Chem; 2015 Oct; 103():252-68. PubMed ID: 26363505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Keap1-Nrf2 system as an in vivo sensor for electrophiles.
    Uruno A; Motohashi H
    Nitric Oxide; 2011 Aug; 25(2):153-60. PubMed ID: 21385624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution.
    Taguchi K; Motohashi H; Yamamoto M
    Genes Cells; 2011 Feb; 16(2):123-40. PubMed ID: 21251164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy.
    Shibata T; Ohta T; Tong KI; Kokubu A; Odogawa R; Tsuta K; Asamura H; Yamamoto M; Hirohashi S
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13568-73. PubMed ID: 18757741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the Nrf2/ARE pathway via S-alkylation of cysteine 151 in the chemopreventive agent-sensor Keap1 protein by falcarindiol, a conjugated diacetylene compound.
    Ohnuma T; Nakayama S; Anan E; Nishiyama T; Ogura K; Hiratsuka A
    Toxicol Appl Pharmacol; 2010 Apr; 244(1):27-36. PubMed ID: 20026152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion dynamics of the Keap1-Cullin3 interaction in single live cells.
    Baird L; Dinkova-Kostova AT
    Biochem Biophys Res Commun; 2013 Mar; 433(1):58-65. PubMed ID: 23454126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of RA839, a Noncovalent Small Molecule Binder to Keap1 and Selective Activator of Nrf2 Signaling.
    Winkel AF; Engel CK; Margerie D; Kannt A; Szillat H; Glombik H; Kallus C; Ruf S; Güssregen S; Riedel J; Herling AW; von Knethen A; Weigert A; Brüne B; Schmoll D
    J Biol Chem; 2015 Nov; 290(47):28446-28455. PubMed ID: 26459563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway.
    Hayes JD; McMahon M; Chowdhry S; Dinkova-Kostova AT
    Antioxid Redox Signal; 2010 Dec; 13(11):1713-48. PubMed ID: 20446772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of the Nrf2/Keap1/ARE signaling system.
    Tkachev VO; Menshchikova EB; Zenkov NK
    Biochemistry (Mosc); 2011 Apr; 76(4):407-22. PubMed ID: 21585316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of the negative regulator of Nrf2, Keap1: a historical overview.
    Itoh K; Mimura J; Yamamoto M
    Antioxid Redox Signal; 2010 Dec; 13(11):1665-78. PubMed ID: 20446768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of NRF2 by nitrosative agents and H2O2 involves KEAP1 disulfide formation.
    Fourquet S; Guerois R; Biard D; Toledano MB
    J Biol Chem; 2010 Mar; 285(11):8463-71. PubMed ID: 20061377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of a high-throughput screen for identifying small molecules to activate the Keap1-Nrf2-ARE pathway.
    Wu KC; McDonald PR; Liu JJ; Chaguturu R; Klaassen CD
    PLoS One; 2012; 7(10):e44686. PubMed ID: 23056183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of Nrf2/Keap1 system by Wasabi 6-methylthiohexyl isothiocyanate in ARE-mediated NQO1 expression.
    Korenori Y; Tanigawa S; Kumamoto T; Qin S; Daikoku Y; Miyamori K; Nagai M; Hou DX
    Mol Nutr Food Res; 2013 May; 57(5):854-64. PubMed ID: 23390006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Keap1-Nrf2 system and diabetes mellitus.
    Uruno A; Yagishita Y; Yamamoto M
    Arch Biochem Biophys; 2015 Jan; 566():76-84. PubMed ID: 25528168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide and small molecule inhibitors of the Keap1-Nrf2 protein-protein interaction.
    Wells G
    Biochem Soc Trans; 2015 Aug; 43(4):674-9. PubMed ID: 26551711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cul3-mediated Nrf2 ubiquitination and antioxidant response element (ARE) activation are dependent on the partial molar volume at position 151 of Keap1.
    Eggler AL; Small E; Hannink M; Mesecar AD
    Biochem J; 2009 Jul; 422(1):171-80. PubMed ID: 19489739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and mechanistic insights into the Keap1-Nrf2 system as a route to drug discovery.
    Madden SK; Itzhaki LS
    Biochim Biophys Acta Proteins Proteom; 2020 Jul; 1868(7):140405. PubMed ID: 32120017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the Kelch-like ECH-associated protein 1 (Keap1)/NF-E2-related factor 2 (Nrf2) pathway through covalent modification of the 2-alkenal group of aliphatic electrophiles in Coriandrum sativum L.
    Abiko Y; Mizokawa M; Kumagai Y
    J Agric Food Chem; 2014 Nov; 62(45):10936-44. PubMed ID: 25307732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the Keap1/Nrf2 pathway in the cellular response to methylmercury.
    Kumagai Y; Kanda H; Shinkai Y; Toyama T
    Oxid Med Cell Longev; 2013; 2013():848279. PubMed ID: 23878621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.